Clinical Trials Start for Stem Cell Alzheimer’s Drug in US – Pharmaceutical Processing
Pharmaceutical Processing |
Clinical Trials Start for Stem Cell Alzheimer's Drug in US
Pharmaceutical Processing Biostar Stem Cell Research Institute, which is co-operated by Nature Cell and R Bio, has developed a technology for culturing autologous fat stem cells. The institute has invested more than KRW 300 billion ($261 million) in its research and development … |
